Skip to main
OPCH

OPCH Stock Forecast & Price Target

OPCH Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 20%
Buy 40%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

Option Care Health is a well-established home and alternate-site infusion services provider, with a strong balance sheet and portfolio split across acute and chronic therapies. Despite potential risks in the regulated healthcare industry, the company's recent merger with BioScrip and positive core growth projections for the second half of 2026 support a positive long-term outlook for investors.

Bears say

Option Care Health is facing challenges with its patient census due to higher-than-anticipated insurance changes, transitioning therapies, and slower growth in certain specialty therapies. These challenges have resulted in a lower patient census and reduced revenue and gross profit expectations for the company. While management is optimistic about its acute therapy business and investment in advanced practitioner capabilities, the company's exposure to Stelara and its limited impact in the future may hinder growth opportunities. There is also uncertainty in the potential for future catalysts and the current valuation seems fair, leading to a negative outlook on the company's stock.

OPCH has been analyzed by 10 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Option Care Health (OPCH) Forecast

Analysts have given OPCH a Buy based on their latest research and market trends.

According to 10 analysts, OPCH has a Buy consensus rating as of Aug 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $75.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $75.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Option Care Health (OPCH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.